DSM FIRMENICH AG
Identification
Listing sponsor / Euronext Growth Advisor
ABN AMRO Bank N.V.
Ticker
DSFIR
Codice ISIN
CH1216478797
codice LEI
506700G44V67MPM4BI12
Mercato
Euronext
Borsa
Amsterdam
Comparto
Compartment A
ICB
45102020 Food Products
Indirizzo web
https://www.creator-innovator.com/
Operation
Data IPO
Mar 18/04/2023
Tipologia IPO
Direct listing
Profilo società
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Fonte:
Cofisem
-
Ultimo aggiornamento:
03 Mar 2025
Dirigenti principali
| Chief Executive Officer | Dimitri de Vreeze | ||||
| Chief Financial Officer | Ralf Schmeitz | ||||
| Director Research & Development | Sarah Reisinger | ||||
| Chief Risk Officer | Jane Sinclair | ||||
| General Counsel | Jane Sinclair | ||||
| Chief Human Resources Officer | Mieke Van de Capelle | ||||
| Fonte: Cofisem - Ultimo aggiornamento: 03 Mar 2025 | |||||
Dati principali
| Millenium | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Net sales | 12.799 | 10.627 | |||
| Income from ordinary activities | 12.799 | 10.627 | |||
| Operating income | 561 | -497 | |||
| Cost of financial indebtedness net | 107 | 55 | |||
| Equity-accounted companies contribution to income | 0 | -7 | |||
| Net profit from discontinued activities | 0 | 2.789 | |||
| Net income | 280 | 2.153 | |||
| Net income (Group share) | 250 | 2.131 | |||
| Fiscal year end | 2024-12-31 | 2023-12-31 | |||
| Length of fiscal year (month) | 12 | 12 | |||
| Currency & Unit | EUR - millions | EUR - millions | |||
| Account Standards | IFRS | IFRS | |||
| Fonte: Cofisem - Ultimo aggiornamento: 03 Mar 2025 | |||||